Myxovirus Resistance Protein A (MxA) in Systemic Lupus Erythematosus: A Review of Recent Advances in Diagnosis and Disease Management
Global Insights in Medicine and Nursing · 2026
DOI: 10.65140/gimn202601.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Insights in Medicine and Nursing, 2026. Verfasst von Haoyang Wang und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can be difficult to track and can be hard to diagnose early and assess treatment effectiveness. Myxovirus resistance protein A (MxA), a downstream effector of type I interferon (IFN-I) signaling, has become an interesting biomarker for SLE. Recent results have found that MxA expression is highly associated with SLE activity, and the specificity of MxA for IFN-I suggest it may be useful biomarker to early diagnose SLE and evaluate activity.This review reviews biological aspects, of MxA, its role in SLE pathology, and how MxA may be a useful biomarkener to diagnose. We review the clinical detection and its use to track flare-ups, and illustrate the ability of MxA to improve clinical assessment and guiding treatment in SLE.
Zitieren
APA
Wang, H., Zhang, X., Liang, Y., Yu, F., Wang, C., & Liu, P. (2026). Myxovirus Resistance Protein A (MxA) in Systemic Lupus Erythematosus: A Review of Recent Advances in Diagnosis and Disease Management. Global Insights in Medicine and Nursing. https://doi.org/10.65140/gimn202601.16
Vancouver
Wang H, Zhang X, Liang Y, Yu F, Wang C, Liu P. Myxovirus Resistance Protein A (MxA) in Systemic Lupus Erythematosus: A Review of Recent Advances in Diagnosis and Disease Management. Global Insights in Medicine and Nursing. 2026. doi:10.65140/gimn202601.16
BibTeX
@article{Wang2026,
author = {Wang, Haoyang and Zhang, Xiuwen and Liang, Yan and Yu, Fei and Wang, Chenyang and Liu, Peng},
title = {Myxovirus Resistance Protein A (MxA) in Systemic Lupus Erythematosus: A Review of Recent Advances in Diagnosis and Disease Management},
journal = {Global Insights in Medicine and Nursing},
year = {2026},
doi = {10.65140/gimn202601.16}
}
EUVIMED